AI Science Tracker
EN

Tumor immune profiles noninvasively estimated by FDG PET with deep learning correlate with immunotherapy response in lung adenocarcinoma.

Affiliation not stated in the reviewed material · 29 Aug 2020 · medicine

Discovery

Tumor immune profiles noninvasively estimated by FDG PET with deep learning correlate with immunotherapy response in lung adenocarcinoma.

Source check: Source checked. Not independent scientific confirmation.

Finding: Publisher PDF Methods/Results report model training on FDG-PET to estimate tumor immune CytAct and tests in separate SNUH, TCGA and immunotherapy cohorts; modest retrospective associations bound the claim. Organization is unavailable in the deposited bibliographic metadata.

Technology: Deep-learning model mapping FDG-PET to tumor immune activity

Publication: Publication status unspecified in annotation · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Deep model estimates RNA-seq-derived immune activation from PET. Independent-cohort correlations and immunotherapy response associations were observed, but cohorts are small and retrospective.
Test and result
Publisher PDF Methods/Results report model training on FDG-PET to estimate tumor immune CytAct and tests in separate SNUH, TCGA and immunotherapy cohorts; modest retrospective associations bound the claim.
Limitation / still unknown
The reviewed study does not establish validation or benefit beyond its reported evaluation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.thno.org/v10p10838.pdf

The legacy label “Not reported” does not distinguish information absent from reviewed material from information not assessed. It is not a scientific finding of absence.

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.